I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
EGFR inhibitors plus bevacizumab are superior than EGFR inh..:
Corrales, Luis
;
Ordóñez-Reyes, Camila
;
Barron, Lucia Zatarain
...
JCO Precision Oncology, 2473-4284, Vol 5, 2021, pag 839-848. , 2021
Link:
https://hdl.handle.net/20.500.12495/7299
RT Journal T1
EGFR inhibitors plus bevacizumab are superior than EGFR inhibitors alone as first-line setting in advanced NSCLC with EGFR mutations and BIM deletion polymorphisms (BIM-CLICaP)
UL https://suche.suub.uni-bremen.de/peid=base-ftunivbosque:oai:repositorio.unbosque.edu.co:20.500.12495_7299&Exemplar=1&LAN=DE A1 Corrales, Luis A1 Ordóñez-Reyes, Camila A1 Barron, Lucia Zatarain A1 Martín, Claudio Marcelo A1 Barrón-Barrón, Feliciano A1 Ruíz-Patiño, Alejandro A1 Recondo, Gonzalo A1 Rojas, Leonardo A1 Sotelo, Carolina A1 Rodríguez, July F A1 Cardona, Andrés Felipe A1 Garcia-Robledo, Juan Esteban PB American Society of Clinical Oncology; JCO Precision Oncology YR 2021 K1 Pacientes con receptor del factor de crecimiento epidérmico (EGFR) K1 Cáncer de pulmón de células no pequeñas (CPCNP) mutado K1 Polimorfismo de eliminación BIM (eliminación BIM) K1 Patients with epidermal growth factor receptor (EGFR) K1 mutated non–small-cell lung cancer (NSCLC) K1 harboring BIM deletion polymorphism (BIM deletion) JF JCO Precision Oncology, 2473-4284, Vol 5, 2021, pag 839-848 LK http://dx.doi.org/https://hdl.handle.net/20.500.12495/7299 DO https://hdl.handle.net/20.500.12495/7299 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)